Vivos Therapeutics
VVOS
VVOS
27 hedge funds and large institutions have $2.82M invested in Vivos Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.05% less ownership
Funds ownership: 0.43% → 0.38% (-0.05%)
58% less capital invested
Capital invested by funds: $6.66M → $2.82M (-$3.84M)
Holders
27
Holding in Top 10
–
Calls
$29K
Puts
$1K
Top Buyers
| 1 | +$17.7K | |
| 2 | +$15K | |
| 3 | +$5.17K | |
| 4 |
WWM
Wagner Wealth Management
Greenville,
South Carolina
|
+$3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3K |
Top Sellers
| 1 | -$456K | |
| 2 | -$188K | |
| 3 | -$64K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$52.5K |
| 5 |
Millennium Management
New York
|
-$30K |